Abnova (Taiwan) Corp 4133
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 30.20
- Day Range
- TWD 30.20–30.65
- 52-Week Range
- TWD 29.80–38.85
- Bid/Ask
- TWD 30.55 / TWD 30.60
- Market Cap
- TWD 1.85 Bil
- Volume/Avg
- 81,000 / 173,962
Key Statistics
- Price/Earnings (Normalized)
- 43.94
- Price/Sales
- 5.07
- Dividend Yield (Trailing)
- 2.65%
- Dividend Yield (Forward)
- 2.65%
- Total Yield
- 2.65%
Company Profile
Abnova (Taiwan) Corp is a manufacturer of antibody and recombinant protein, including monoclonal antibodies, polyclonal antibodies, and protein-related products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 190
- Website
- https://www.abnova.com
Comparables
Valuation
|
Metric
|
4133
|
6586
|
6733
|
|---|---|---|---|
Price/Earnings (Normalized) | 43.94 | — | — |
Price/Book Value | 1.50 | 3.88 | 4.85 |
Price/Sales | 5.07 | — | 40.59 |
Price/Cash Flow | 26.32 | — | — |
Price/Earnings
4133
6586
6733
Financial Strength
|
Metric
|
4133
|
6586
|
6733
|
|---|---|---|---|
Quick Ratio | 7.90 | 24.57 | 16.25 |
Current Ratio | 14.69 | 24.93 | 17.32 |
Interest Coverage | 268.53 | −4,185.04 | −671.31 |
Quick Ratio
4133
6586
6733
Profitability
|
Metric
|
4133
|
6586
|
6733
|
|---|---|---|---|
Return on Assets (Normalized) | 3.20% | −12.79% | −15.44% |
Return on Equity (Normalized) | 3.45% | −13.78% | −17.18% |
Return on Invested Capital (Normalized) | 2.70% | −14.59% | −17.19% |
Return on Assets
4133
6586
6733
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Gnvvywzjr | Vfq | $557.8 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cfttpft | Yrkqj | $103.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Dzynglgj | Tprzl | $98.8 Bil | |
MRNA
| Moderna Inc | Cdtgdkgkb | Zxfv | $38.8 Bil | |
ARGX
| argenx SE ADR | Gltwvtpg | Pprt | $21.3 Bil | |
BNTX
| BioNTech SE ADR | Hqsmgfcf | Zxdg | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zjxmxzxv | Qzlbh | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xjygncdm | Svhxd | $17.0 Bil | |
RPRX
| Royalty Pharma PLC Class A | Chjnzrcbbv | Fhnkhyp | $12.4 Bil | |
INCY
| Incyte Corp | Sncxdwpg | Qqjgw | $11.9 Bil |